Pharmafile Logo
Pharmafocus logo
Advanced Search

Sanofi Pasteur

Showing 9 posts of 24 posts found.

Prevenar 13 image

Prevenar 13 rejected for UK vaccination programme

July 27, 2012
Sales and Marketing JCVI, Pfizer, Pneumovax, Sanofi Pasteur, prevenar 13

The UK’s joint committee on vaccination and immunisation is recommending against a switch to Pfizer’s pneumococcal vaccine Prevenar 13 from …

News

Digital Pharma: Sanofi Pasteur MSD takes Quora approach to vaccines

May 6, 2011
Medical Communications Digital Pharma blog, Sanofi Pasteur, vaccines

Sanofi Pasteur MSD is aiming to tackle myths and misconceptions about vaccines with a Quora-like online health information campaign in …

News

Sanofi partners on dengue vaccine awareness

February 22, 2011
Medical Communications, Research and Development Dengue Vaccine Institute, Dengue fever, International Vaccine Institute, Sanofi Pasteur, Sanofi-Aventis, disease awareness, vaccines

Sanofi-Aventis has teamed up with the International Vaccine Institute to raise awareness about dengue fever and its vaccine for the …

News

Sanofi’s C diff vaccine fast tracked by FDA

November 10, 2010
Research and Development C diff, C diff vaccine, C difficile, Clostridium difficile, FDA, FDA fast-track, Sanofi, Sanofi Pasteur

A new vaccine aimed at preventing C difficile infections has been fast tracked by the FDA. The regulator’s decision signals …

News

Sanofi plant in France under FDA scrutiny

August 3, 2010
Manufacturing and Production Sanofi Pasteur, manufacturing compliance

Sanofi-Aventis failed to follow proper quality control procedures at a vaccine manufacturing plant in France, according to the US Food …

News

Sanofi to develop monoclonal antibody jabs

June 8, 2010
Research and Development Sanofi Pasteur, Vivalis, vaccines

Sanofi-Aventis is to develop a range of monoclonal antibody for use against infectious diseases. The French pharma company’s vaccines arm …

News

Sanofi refocuses its French manufacturing capacity

April 1, 2010
Manufacturing and Production Dengue fever, Sanofi Pasteur, biologics

Sanofi-Aventis has set aside a 150 million euro ($200m) war chest to fund a major expansion of its biologic manufacturing …

News

Sanofi’s Humenza poised to be Europe’s fifth swine flu vaccine

February 22, 2010
Sales and Marketing Sanofi Pasteur, Tyverb, Zeftera, swine flu

Sanofi Pasteur’s Humenza is set to become the fifth swine flu vaccine in Europe after gaining the support of a …

News

Sanofi Pasteur collaborates on novel biologics

January 12, 2010
Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines

Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026